WBA vs. DNA

In the year-to-date period, WBA achieves a 18.01% return, which is significantly higher than DNA's -20.16% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Walgreens Boots Alliance, Inc. (WBA) and Ginkgo Bioworks Holdings, Inc. (DNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current WBA Sharpe Ratio is -0.55, which is comparable to the DNA Sharpe Ratio of -0.68. The chart below compares the historical Sharpe Ratios of WBA and DNA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

WBA's dividend yield for the trailing twelve months is around 6.81%, while DNA has not paid dividends to shareholders.

The maximum WBA drawdown since its inception was -87.93%, smaller than the maximum DNA drawdown of -99.10%. Use the drawdown chart below to compare losses from any high point for WBA and DNA. For additional features, visit the drawdowns tool.

The current volatility for Walgreens Boots Alliance, Inc. (WBA) is 4.99%, while Ginkgo Bioworks Holdings, Inc. (DNA) has a volatility of 32.07%. This indicates that WBA experiences smaller price fluctuations and is considered to be less risky than DNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Walgreens Boots Alliance, Inc. and Ginkgo Bioworks Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.